6Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide bur- den of cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer, 2010,127(12) :2 893 -2 917.
7Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [ J]. CA Cancer J Clin,2013,63 ( 1 ) : 11 - 30.
8U. S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common ter- minology criteria for adverse events ( CTCAE ) version 4.0 [Z/OL]. [2009-05-283 (2015-11-30). http://evs, nei. nih. gov/ftpl/CTCAE/CTCAE_4.03 _2010-06-14_Quick- Reference_5x7. pdf.
9Lew DT,Blachman K,Zaloshnja E.Chapter 10:a macromodel of smoking and lung cancer,examining aggregate trends in lung cancer rates using the CPS-Ⅰand CPS-Ⅱand two-stage clonal expansion models[J].Risk Anal,2012,32(Suppl 1):125.
10Zhou J,Zhao WY,Ma X,et al.The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626.